Related content

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

By Li Sophia   Kaur Primal   Chan Virginia   Berney Steven  

Clinical Rheumatology, Vol. 28, Iss. 7, 2009-07 ,pp. : 787-791

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of TNFα-Inhibitors on Cardiovascular Events in Patients with Rheumatoid Arthritis: An Updated Systematic Review of the Literature

By  

Current Rheumatology Reviews, Vol. 12, Iss. 3, 2016-12 ,pp. : 208-222

Bentham Science Publishers

Access to resources Recommend Favorite

The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients

By van Hoogmoed D   Fransen J   Repping-Wuts H   Spee L   Bleijenberg G   van Riel PLCM  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 1, 2013-01 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite

Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression

By Nishina Naoshi   Kaneko Yuko   Kameda Hideto   Kuwana Masataka   Takeuchi Tsutomu  

Clinical Rheumatology, Vol. 32, Iss. 11, 2013-11 ,pp. : 1661-1666

Springer Publishing Company

Access to resources Recommend Favorite

Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFα therapy

By Rosenvinge A.   Krogh-Madsen R.   Baslund B.   Pedersen B. K.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 2, 2007-01 ,pp. : 91-96

Informa Healthcare

Access to resources Recommend Favorite